NDC Product Labeler Takeda Pharmaceutical Company Ltd

Takeda Pharmaceutical Company Ltd labeler's code is 11532. The labeler has 39 products that have an assigned National Drug Code.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Product Type Status
11532-1145Kapidex
11532-1146Kapidex
11532-0011 PioglitazoneTabletDrug For Further ProcessingUNFINISHED
11532-0012 PioglitazoneTabletDrug For Further ProcessingUNFINISHED
11532-0013 PioglitazoneTabletDrug For Further ProcessingUNFINISHED
11532-0021 Pioglitazone Hydrochloride And Metformin HydrochlorideTabletDrug For Further ProcessingUNFINISHED
11532-0022 Pioglitazone Hydrochloride And Metformin HydrochlorideTabletDrug For Further ProcessingUNFINISHED
11532-1251 Alogliptin And Metformin HydrochlorideTablet, Film CoatedDrug For Further ProcessingUNFINISHED
11532-1255 Alogliptin And Metformin HydrochlorideTablet, Film CoatedDrug For Further ProcessingUNFINISHED
11532-1450 Leuprolide AcetateInjection, Powder, Lyophilized, For SuspensionDrug For Further ProcessingUNFINISHED
11532-1451 Leuprolide AcetateInjection, Powder, Lyophilized, For SuspensionDrug For Further ProcessingUNFINISHED
11532-1452 Leuprolide AcetateInjection, Powder, Lyophilized, For SuspensionDrug For Further ProcessingUNFINISHED
11532-1453 Leuprolide AcetateInjection, Powder, Lyophilized, For SuspensionDrug For Further ProcessingUNFINISHED
11532-1454 Leuprolide AcetateInjection, Powder, Lyophilized, For SuspensionDrug For Further ProcessingUNFINISHED
11532-1455 Leuprolide AcetateInjection, Powder, Lyophilized, For SuspensionDrug For Further ProcessingUNFINISHED
11532-1456 Leuprolide AcetateInjection, Powder, Lyophilized, For SuspensionDrug For Further ProcessingUNFINISHED
11532-1457 Leuprolide AcetateInjection, Powder, Lyophilized, For SuspensionDrug For Further ProcessingUNFINISHED
11532-2002 Azilsartan KamedoxomilTabletDrug For Further ProcessingUNFINISHED
11532-2003 Azilsartan KamedoxomilTabletDrug For Further ProcessingUNFINISHED
11532-3002 VedolizumabInjection, Powder, Lyophilized, For SolutionDrug For Further ProcessingUNFINISHED
11532-3023 Pioglitazone Hydrochloride And GlimepirideTabletDrug For Further ProcessingUNFINISHED
11532-3043 Pioglitazone Hydrochloride And GlimepirideTabletDrug For Further ProcessingUNFINISHED
11532-3338 Leuprolide AcetateInjection, Powder, Lyophilized, For SuspensionDrug For Further ProcessingUNFINISHED
11532-3662 Leuprolide AcetateInjection, Powder, Lyophilized, For SuspensionDrug For Further ProcessingUNFINISHED
11532-3680 Leuprolide AcetateInjection, Powder, Lyophilized, For SuspensionDrug For Further ProcessingUNFINISHED
11532-5001 Pioglitazone HydrochloridePowderBulk IngredientUNFINISHED
11532-6001 Azilsartan Medoxomil And ChlorthalidoneTabletDrug For Further ProcessingUNFINISHED
11532-6002 Azilsartan Medoxomil And ChlorthalidoneTabletDrug For Further ProcessingUNFINISHED
11532-6003 Azilsartan Medoxomil And ChlorthalidoneTabletDrug For Further ProcessingUNFINISHED
11532-6004 Azilsartan Medoxomil And ChlorthalidoneTabletDrug For Further ProcessingUNFINISHED
11532-7001 AlogliptinTablet, Film CoatedDrug For Further ProcessingUNFINISHED
11532-7002 AlogliptinTablet, Film CoatedDrug For Further ProcessingUNFINISHED
11532-7003 AlogliptinTablet, Film CoatedDrug For Further ProcessingUNFINISHED
11532-7101 Alogliptin/pioglitazoneTablet, Film CoatedDrug For Further ProcessingUNFINISHED
11532-7102 Alogliptin/pioglitazoneTablet, Film CoatedDrug For Further ProcessingUNFINISHED
11532-7103 Alogliptin/pioglitazoneTablet, Film CoatedDrug For Further ProcessingUNFINISHED
11532-7104 Alogliptin/pioglitazoneTablet, Film CoatedDrug For Further ProcessingUNFINISHED
11532-7105 Alogliptin/pioglitazoneTablet, Film CoatedDrug For Further ProcessingUNFINISHED
11532-7106 Alogliptin/pioglitazoneTablet, Film CoatedDrug For Further ProcessingUNFINISHED